Manhattan Scientifics Inc. (OTCQB: MHTX), which provided the initial funding &, currently owns more than 50 million shares of Imagion Biosystems Ltd. celebrates Imagion’s remarkable progress in early cancer detection technology.
May 31, 2023
· 2 min read